Caprelsa

Product manufactured by Genzyme Corporation

Application Nr Approved Date Route Status External Links
NDA022405 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Caprelsa Is Indicated For The Treatment Of Symptomatic Or Progressive Medullary Thyroid Cancer In Patients With Unresectable Locally Advanced Or Metastatic Disease. Use Caprelsa In Patients With Indolent, Asymptomatic Or Slowly Progressing Disease Only After Careful Consideration Of The Treatment Related Risks Of Caprelsa. Caprelsa Is A Kinase Inhibitor Indicated For The Treatment Of Symptomatic Or Progressive Medullary Thyroid Cancer In Patients With Unresectable Locally Advanced Or Metastatic Disease. ( 1 ) Use Caprelsa In Patients With Indolent, Asymptomatic Or Slowly Progressing Disease Only After Careful Consideration Of The Treatment Related Risks Of Caprelsa. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Vandetanib VANDETANIB ZINC53683345

Comments